痴呆症护理的沉浸式,开放世界的虚拟现实:NeuroVRX试点研究
Martin Eckert1,2, Thomas Ostermann2, Jan Peter Ehlers2
1Stabsstelle für Digitalisierung und Wissensmanagement, Hochschule Hamm-Lippstadt, 59063 Hamm, Germany.
Journal of clinical medicine
|December 11, 2025
概括
这项试点研究发现,沉浸式的开放世界虚拟现实 (VR) 是痴呆症患者的可行,安全和可接受的干预措施. 虚拟现实提供认知和运动刺激,支持其在未来的治疗试验中使用.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 人与计算机的交互
背景情况:
- 阿尔茨海默病和相关的痴呆症对全球健康和经济构成越来越大的挑战.
- 认知刺激疗法 (CST) 为痴呆症患者提供非药物效益.
- 对于痴呆症的数字和虚拟现实 (VR) 干预措施,特别是在开放世界的环境中,仍未得到充分探索.
研究的目的:
- 评估沉浸式,开放世界的VR应用程序的可行性,可接受性和安全性,用于被诊断为痴呆症的人.
- 探索虚拟现实的潜力,作为这种人群认知和运动刺激的工具.
主要方法:
- 一个单臂的非随机试点研究,涉及三个患有痴呆症的男性参与者.
- 参与者在一个沉浸式的,开放的世界环境中进行一次VR会议,通过坐着的手臂和头部运动自由导航.
- 收集的数据包括会话持续时间,虚拟运动指标以及通过问卷和事报告的参与者反.
主要成果:
- 所有参与者在没有任何不良事件或网络疾病的情况下完成了VR会议.
- 平均会议时间为28分钟,参与者几乎覆盖了0.9公里 (1210步).
- 调查问卷显示了积极的可用性和接受性; 事反强调了沉浸和自传刺激,心情变化最小.
结论:
- 沉浸式的,开放的VR世界是一个可行的,安全的,和被接受的干预为痴呆症患者.
- 先进的硬件和探索性的VR软件的结合提供了认知和运动刺激.
- 结果支持3D探索性VR应用的潜力,并为治疗疗效评估提供了进一步的受控试验.
相关概念视频
Dementia
486
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
486
Alzheimer's Disease: Treatment
752
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
752
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


